RADIOMETER MEDICAL ApS — Regnskab

CVR 27509185

Seneste regnskabsperiode

2025 • 2025-01-01 • 2025-12-31 • entity • DKK • 5860797000 • 2524495000 • 978274000 • 851025000 • 5804826000 • 4304905000 • 1194

Regnskabshistorik

2024 • 2024-01-01 • 2024-12-31 • entity • DKK • 5857290000 • 2448989000 • 913581000 • 841100000 • 5750849000 • 4236188000 • 1164
2023 • 2023-01-01 • 2023-12-31 • entity • DKK • 5587559000 • 1144055000 • 1018830000 • 5837791000 • 4367501000 • 1142
2022 • 2022-01-01 • 2022-12-31 • entity • DKK • 5505971000 • 494470000 • 477894000 • 5419419000 • 3946788000 • 1188
2021 • 2021-01-01 • 2021-12-31 • entity • DKK • 5047156000 • 904213000 • 783413000 • 7107342000 • 5368768000 • 1164
2020 • 2020-01-01 • 2020-12-31 • entity • DKK • 4686744000 • 958191000 • 824462000 • 8546048000 • 7084601000 • 1134
2019 • 2019-01-01 • 2019-12-31 • entity • DKK • 4344060000 • 802858000 • 715814000 • 7707180000 • 6262486000 • 1101
2018 • 2018-01-01 • 2018-12-31 • entity • DKK • 3792825000 • 1804192000 • 575226000 • 555909000 • 15220638000 • 13711504000 • 1068
2017 • 2017-01-01 • 2017-12-31 • entity • DKK • 3586975000 • 1686110000 • 501459000 • 466015000 • 14788341000 • 13155595000 • 1035

Højdepunkter fra årsrapporten

primary activities • Principal activitites When life takes an unexpected turn, Radiometer´s technology and solutions enable caregivers to make informed diagnostic decisions to improve patient care.For health care professionals working with critically ill patients, life is not a given - it is the ultimate goal. Radiometer's goal is to help them.To do this, Radiometer continually seeks deep insights to improve customer experiences. This forms Radiometer's foundation for innovation and enables the Company to continue to provide powerful acute care diagnostic solutions including blood sampling, blood gas analysis, transcutaneous monitoring, immunoassay testing and the related IT management systems and digital services.Radiometer´s lean and agile business model enables the employees located in 42 countries to grow and succeed using the Danaher Business System to construct sustainable processes. Guiding the efforts are four simple, customer-facing priorities: quality, delivery, cost and innovation.The Company develops and produces the products together with the other production companies in the Radiometer Group and distributes the products to customers globally through the sales companies in the Group, through external distributors and to the end-users in Denmark.Special risks The Company monitors the risk factors that may affect the operations and financial results on a regular basis. The identified risks are seeked minimised by operational countermeasures and through insurance. Below is a more detailed description of these factors.Currency risks: The Company's net payments in foreign currencies are usually sold immediately after receipt. There is no hedging of currency risk on foreign currency assets and liabilities.Credit risks: 84% of the Company´s products are sold to sales companies within the Group, where the credit risk is considered limited. 16% of the products are sold to external non-affiliated distributors, who are subject to ongoing credit evaluation. Some of them have a long-time business relationship and therefor the risk is also considered limited for the sales to distributors.Dependence on customers: Revenue is distributed among a large number of markets and a very large number of individual customers, so dependence on individual customers is considered small.Technology development: It is the opinion of the Company that neither in the short- nor medium term will new disruptive technologies appear which would reduce the demand for the product portfolio of the Company on at short notice. Rapid technological developments in artificial intelligence is a risk for the industry and can potentially in the longer term affect demand of products and services, positive and negative, just as it is expected to impact time to market for development of products and solutions.Product liability and business liability: The Company has covered product and business liability risk by an adequate insurance with a premium rated insurer.Damage to property and business interruption: Plant and machinery, fixtures and equipment and inventories are insured at replacement value. Significant interruptions of production are covered by a business interruption insurance with a premium-rated insurer.Supplier and material risk: In order to minimize disruption caused by supplier failure, the Company purchases a wide range of components from more than one supplier. For certain critical components inventory is maintained to ensure uninterrupted production in a short time period. • entity
development in activities and financial affairs • Financial review The Company´s income statement for the year ended 31 December 2025 shows revenue of 5.861 MDKK, profit for the year of 851 MDKK, and the balance sheet on 31 December 2025 shows equity of 4.305 MDKK and total assets 5.805 MDKK. Revenue for the year increased by 0.1% to 5.861 MDKK (2024: 5.857 MDKK). The increase in revenue was impacted negatively by development in foreign currency of -224 MDKK/3.8%, leaving a core growth excluding the negative currency impact of 228 MDKK/3.9%. The growth excluding negative currency impact is slightly below the expectations of 4-7% increase for the year. The profit for the year increased 10 MDKK/1.2% to 851 MDKK (2024: 841 MDKK). This was lower than the expected level for the year of 25-35% increase and mainly driven by the negative impact from foreign currencies. During 2025 the Company paid 700 MDKK in dividend and equity therefore slightly increased compared to last year. The Board of Executives recommends distribution of the profit as stated under the proposed distribution of profit, including a dividend of 800 MDKK. • entity
expected development • Future expectationsDeliveries to customers, market access, and quality are continued strategic priorities for the Company. The current business environment continues to be uncertain and can be significantly impacted by exchange rate changes, energy and transportation risks and trade barriers. Core revenue growth is therefore expected to grow 3-6% in 2026, a little higher than the 2025 currency-adjusted growth. Profit for the year is expected to grow in the level of 3-10%, mainly driven by the expected sales growth, but can be significantly impacted by the mentioned uncertainties in the current business environment. • entity
management review • Data ethics • entity
subsequent events • Significant events occurring after the end of the financial yearNo significant events have occured after the end of the financial year with considerable importance for the Company´s financial position. • entity
subsequent events • No substantial events have occured after the end of the financial year with considerable importance for the Company's financial position. • entity
contingent liabilities • Joint taxation The Company is jointly taxed with Danaher Tax Administration ApS, which is the management company (Administrationsselskab) for the Danish joint taxation. The Company is jointly and unlimited liable with the other jointly taxed companies for payment of corporation tax and for withholding tax on interest, royalties and dividends.Other ContingenciesThe Company has rent liabilities of 43.278 TDKK (in 2024: 42.181 TDKK). The rent is indexed annually with the net price index and is interminable until 1st of January 2027. The Company has car lease liabilities of 2.754 TDKK (in 2024: 5.216 TDKK). Of this 1.517 TDKK is due within 1 year (2024: 2.695 TDKK). Bank guarantees of 1.000 TDKK has been signed through the Company's banks (in 2024: 2.394 TDKK). The Company guarantees a credit limit of 40.000 TDKK for the Group companies' cash pool (in 2024: 40.000 TDKK). • entity